Perigon Wealth Management LLC Acquires 1,184 Shares of Colgate-Palmolive (NYSE:CL)

Perigon Wealth Management LLC raised its holdings in Colgate-Palmolive (NYSE:CL) by 3.6% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 33,677 shares of the company’s stock after buying an additional 1,184 shares during the period. Perigon Wealth Management LLC’s holdings in Colgate-Palmolive were worth $2,982,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. FMR LLC grew its stake in shares of Colgate-Palmolive by 65.6% in the third quarter. FMR LLC now owns 6,749,275 shares of the company’s stock valued at $700,642,000 after acquiring an additional 2,674,807 shares in the last quarter. Barclays PLC grew its position in shares of Colgate-Palmolive by 38.7% during the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock worth $793,542,000 after purchasing an additional 2,132,747 shares in the last quarter. State Street Corp increased its holdings in shares of Colgate-Palmolive by 3.8% during the third quarter. State Street Corp now owns 48,436,276 shares of the company’s stock worth $5,028,170,000 after purchasing an additional 1,784,411 shares during the period. Nordea Investment Management AB raised its position in shares of Colgate-Palmolive by 32.5% in the fourth quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company’s stock valued at $462,121,000 after buying an additional 1,247,731 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. boosted its stake in shares of Colgate-Palmolive by 864.1% in the third quarter. Jacobs Levy Equity Management Inc. now owns 777,854 shares of the company’s stock valued at $80,749,000 after buying an additional 697,168 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Trading Down 1.4 %

CL opened at $89.92 on Wednesday. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. Colgate-Palmolive has a fifty-two week low of $82.68 and a fifty-two week high of $109.30. The company’s 50 day moving average price is $91.74 and its two-hundred day moving average price is $97.40. The firm has a market capitalization of $73.47 billion, a price-to-earnings ratio of 25.77, a PEG ratio of 3.59 and a beta of 0.44.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be paid a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.22%. Colgate-Palmolive’s dividend payout ratio is 57.31%.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.34% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the company. UBS Group dropped their price objective on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a report on Thursday, January 16th. Wells Fargo & Company dropped their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research note on Tuesday, January 7th. Piper Sandler reduced their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday, January 6th. StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Finally, JPMorgan Chase & Co. cut their price target on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a report on Thursday, January 16th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $101.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.